Skip to main content
Balaji Amines Ltd. logo

Balaji Amines Ltd. — Investor Relations & Filings

Ticker · BALAMINES ISIN · INE050E01027 LEI · 3358009DS8RG4Z8QBD69 BSE.NS Manufacturing
Open in API
Filings indexed 743 across all filing types
Latest filing 2024-11-14 Interim / Quarterly Rep…
Country IN India
Listing BSE.NS BALAMINES

About Balaji Amines Ltd.

https://www.balajiamines.com/

Balaji Amines Ltd. is a leading manufacturer specializing in Aliphatic Amines, their derivatives, and specialty chemicals. The company produces a diverse range of products, including Methylamines, Ethylamines, and specialty chemicals such as N-Methyl-2-Pyrrolidone (NMP), Morpholine, Dimethylformamide (DMF), and Gamma-Butyrolactone (GBL). Its portfolio serves critical sectors including pharmaceuticals, agrochemicals, refineries, water treatment, and personal care. Utilizing advanced manufacturing technologies and vertically integrated processes, the company maintains a significant market presence in the production of amines and downstream derivatives. Balaji Amines is recognized for its large-scale production capacity and its role as a key supplier of essential chemical intermediates used in the synthesis of active pharmaceutical ingredients and crop protection chemicals.

Recent filings

Filing Released Lang Actions
Press Release
Interim / Quarterly Report Classification · 95% confidence The document is a press release announcing unaudited financial results for the quarter and half year ended September 30, 2024. It contains detailed financial data such as revenue, EBITDA, PAT, margins, and volumes for Q2FY25 and H1FY25, along with commentary from the Managing Director and updates on new projects. The document is over 11,000 characters, indicating it is a substantive report rather than a brief announcement. The content aligns with a quarterly financial report providing comprehensive financial results and business updates for a period shorter than a full fiscal year. Therefore, it fits the definition of an Interim / Quarterly Report (IR). Q2 2025
2024-11-14 English
Appointment
Regulatory Filings
2024-11-14 English
Resignation
Regulatory Filings
2024-11-14 English
Outcome of Board Meeting
Regulatory Filings
2024-11-14 English
Financial Result Updates
Regulatory Filings
2024-11-14 English
Analysts/Institutional Investor Meet/Con. Call Updates
Regulatory Filings Classification · 95% confidence The document is a notification about a scheduled conference call to discuss the Q2FY25 financial results of Balaji Amines Limited. It includes details such as the date, time, and dial-in numbers for the call, but does not contain any actual financial data or results. The document is an announcement of an event related to financial results, not the results themselves or a transcript of the call. Therefore, it fits the category of a Call Transcript (CT) only if it contained the full transcript, which it does not. It is also not an Earnings Release (ER) since it does not provide financial highlights. The best fit is a Regulatory Filing (RNS) as it is a general regulatory announcement about the scheduling of a conference call.
2024-11-13 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.